Durvalumab Intravenous and Symbicort

• Generic Name: durvalumab
• Dosage Forms: n.a.
• Other Brand Names: Imfinzi

Durvalumab injection is used to treat urothelial carcinoma (a type of bladder cancer) that has spread throughout the body (metastatic) or cannot be removed by surgery (advanced). Durvalumab is given to patients who have received other cancer medicines (eg, platinum) but did not work well.

Durvalumab injection is also used to treat non-small cell lung cancer (NSCLC) that has not spread and cannot be removed by surgery. It is given to patients who have received other cancer medicines (eg, platinum) and radiation treatment for their NSCLC.

Durvalumab is to be given only by or under the supervision of your doctor.

• Generic Name: budesonide / formoterol
• Dosage Forms: aerosol
• Other Brand Names: Symbicort, Symbicort Turbuhaler, Symbicort 400/12 Turbohaler

Symbicort contains a combination of budesonide and formoterol. Budesonide is a corticosteroid that reduces inflammation in the body. Formoterol is a long-acting bronchodilator that relaxes muscles in the airways to improve breathing.

Symbicort is used to control and prevent the symptoms of asthma in adults and children at least 6 years old.

Symbicort is also used to help control the symptoms of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Symbicort is not for use in treating an asthma or bronchospasm attack.

For people with asthma: Symbicort is for use only if asthma is severe or is not well-controlled on other long-term asthma medicines. Your doctor may tell you to stop using this medicine once your asthma is well-controlled.

Formoterol when used alone may increase the risk of death in people with asthma. However, this risk is not increased when budesonide and formoterol are used together as a combination product.